<DOC>
	<DOCNO>NCT00997828</DOCNO>
	<brief_summary>The purpose study determine whether safety efficacy coronary stent implantation use Everolimus-Eluting Coronary Stent System ( Abbott , Boston Scientific ) inferior coronary artery bypass grafting ( CABG ) treatment patient multivessel coronary artery disease ( CAD ) .</brief_summary>
	<brief_title>Bypass Surgery Versus Everolimus-Eluting Stent Implantation Multivessel Coronary Artery Disease ( BEST )</brief_title>
	<detailed_description>The primary purpose BEST Study determine whether safety efficacy coronary stent implantation use everolimus-eluting balloon expandable stent inferior coronary artery bypass graft treatment multivessel coronary artery disease .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Age 18 year old Angiographically confirm multivessel CAD [ critical ( &gt; 70 % ) lesion least two major epicardial vessel least two separate coronary artery territory ( LAD , LCX , RCA ) ] amenable either PCI CABG . Indication revascularization base upon symptom angina and/or objective evidence myocardial ischemia Geographically accessible willing come require study visit Signed informed consent . Severe congestive heart failure ( class III IV accord NYHA , pulmonary edema ) time enrollment . Planned simultaneous surgical procedure unrelated coronary revascularization ( e.g . valve repair/replacement , aneurysmectomy , carotid endarterectomy carotid stent ) . Instent restenosis target vessel Prior CABG surgery Prior PCI stent implantation within 1 year Two chronic total occlusion major coronary territory Acute STelevation MI ( Qwave ) within 72 hour prior enrollment require revascularization Abnormal creatine kinase ( CK &gt; 2x normal ) and/or abnormal CKMB level and/or elevate Troponin level time randomization Previous stroke within 6 month patient stroke 6 month significant residual neurologic involvement , reflect Rankin Score &gt; 1 Dementia Mini Mental Status Examination ( MMSE ) score â‰¤ 20 Extracardiac illness expect limit survival le 2 year ; e.g . oxygendependent chronic obstructive pulmonary disease , active hepatitis significant hepatic failure , severe renal disease . Prior history significant bleeding ( within previous 6 month ) might expect occur CABG PCI/DES related anticoagulation . Contraindication either CABG PCI/DES coexist clinical condition Significant leucopenia , neutropenia , thrombocytopenia , anemia , know bleed diathesis Intolerance contraindication aspirin clopidogrel ticlopidine Suspected pregnancy . A pregnancy test ( urine serum ) administer prerandomization woman clearly menopausal Concurrent enrollment another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>stent</keyword>
	<keyword>coronary artery bypass graft surgery</keyword>
	<keyword>multivessel coronary artery disease</keyword>
</DOC>